We recently identified the transcription factor Forkhead Box C2 (FOXC2) as a key regulator of EMT and stem cell properties, including tumour-initiation capacity, metastatic competence, and chemotherapy resistance27, 28. Here, FOXC2 is linked to neoplasm.